Project description
Deprescribing safely: monitoring adverse drug withdrawal events
For medications that may no longer be beneficial or might be causing harm, and especially in the case of polypharmacy, clinicians often resort to a planned and supervised process of dose reduction or stopping medications. This process is known as deprescribing; its goal is to improve outcomes and reduce the risk of adverse drug events. Funded by the Marie Skłodowska-Curie Actions programme, the HEAD-P project aims to enhance understanding of adverse drug withdrawal events (ADWEs) and improve their monitoring through pharmacovigilance. Researchers will examine ADWE incidence and review recommendations on ADWE monitoring, while exploring ways of integrating ADWE results into pharmacovigilance.
Objective
Deprescribing (reducing or stopping unnecessary or harmful medications) is an important strategy to reduce the risk of medication harm – a significant and growing challenge for health systems as acknowledged by the World Health Organization. The aim of HEAD-P is to establish the current evidence base on adverse drug withdrawal events (ADWEs) and explore how this can be enhanced via the pharmacovigilance system. HEAD-P consists of 4 research objectives: to assess the rate of ADWEs in published trials of deprescribing; to examine the incidence of adverse events reporting related to ADWEs; to identify and review all recommendations related to the monitoring, detection, and reporting of ADWEs; and to investigate healthcare professional, patient, and policymaker perspectives on the integration of ADWE reporting in the pharmacovigilance system. The following research approaches will be employed: an umbrella review of systematic reviews, disproportionality analysis of key pharmacovigilance databases, a scoping review of sources of guidance, and qualitative semi-structured interviews. This innovative research will help address the significant gap in our knowledge of ADWE occurrence and will stimulate future studies and innovations. Moreover, this fellowship will provide me with valuable scientific (protocol development, quantitative data analysis relevant to pharmacovigilance data, qualitative research methods, data management, and synthesis skills) and transferrable (grant writing, research communication, and supervision and mentoring skills) skills. It will also provide me with valuable international, intersectoral, and interdisciplinary experience, and allow me to develop leaderships skills. The skills and experience I will gain by completing this Fellowship in the host organisation (RCSI), will help me achieve my ultimate career goal – to become a leader in pharmacovigilance research and development in academia or a medicines regulatory agency.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2023-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
2 DUBLIN
Ireland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.